Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Fig 1.

Analysis of cell viability after 72 h treatment with Hsp90 inhibitors NVP-AUY922, BIIB021 and AT-13387.

(A) Toxicity of NVP-AUY922 and BIIB021 in MCF7 cells did not reach 50% in 72 h. All experiments were repeated 4 times. (B) Comparison of IC20 of Hsp90 inhibitors in breast cancer cell lines. (C) The comparison of sensitivity based on p53 status, Her2 (ErbB2) status, and subtype of breast cancer.

More »

Fig 1 Expand

Fig 2.

Analysis of HSF1 in response to NVP-AUY922.

(A) Western blot analysis of phosphorylated HSF1 (Ser326) and total HSF1 in breast cancer cell lines. A representative blot is shown of 3 biological replicates. (B) Graph shows increase in ratio of pSer326HSF1 to total HSF1 after 4 h treatment with 200 nM NVP-AUY922 correlated to IC20 (nM) values of NVP-AUY922 treated breast cancer cell lines (r = 0.718; p = 0.0161).

More »

Fig 2 Expand

Fig 3.

Viability analysis of SK-BR-3 and T-47D cells.

SK-BR-3 and T-47D cells were cultivated in physiological conditions (37 °C) and elevated temperature (39 °C) after 72 h NVP-AUY922 treatment. Viability analysis was performed in 3 biological replicates. (* p = 0,0377; **p = 0,0023).

More »

Fig 3 Expand

Fig 4.

Correlation of HSF1 basal activity characterised by HOP/CHIP ratio with sensitivity to Hsp90 inhibitors.

(A-C) HSF1 activity expressed as the ratio between the HSF1 regulated co-chaperone HOP and the HSF1 independent co-chaperone CHIP correlated with IC20 (nM) of the indicated Hsp90 inhibitors. (A) NVP-AUY922 (r = -0.707; p = 0.0178), (B) BIIB021 (r = -0.602; p = 0.0402) and (C) AT13387 (r = -0.530; p = 0.0637). (D) mRNA copy number of analysed genes per reaction. qPCR measurements were performed from 3 biological replicates.

More »

Fig 4 Expand

Fig 5.

Correlation of HSF1 basal activity with sensitivity characterised by Hsp70/CHIP ratio to Hsp90 inhibitors.

(A-C) HSF1 activity expressed as the ratio between the HSF1 regulated co-chaperone Hsp70 and the HSF1 independent co-chaperone CHIP correlated with IC20 (nM) of the indicated Hsp90 inhibitors. (A) NVP-AUY922 (r = -0.711; p = 0.0171), (B) BIIB021 (r = -0.660; p = 0.0265) and (C) AT13387 (r = -0.591; p = 0.0435). (D) mRNA copy number of analysed genes per reaction. qPCR measurements were performed from 3 biological replicates.

More »

Fig 5 Expand